rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Gleevec

Rediff.com  »  News  »   Gleevec

  News for Gleevec

  • Business

Sun Pharma settles litigation with Novartis over cancer drug

Sun Pharma has inked a settlement pact with Novartis Pharmaceutical Corporation over cancer drug Gleevec, paving the way for the Indian drug major to launch a generic version of the medicine in the......

Sun Pharma sues Novartis in US court

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New......

Novartis denied patent for cancer drug

The Patent Controller Office of India has rejected the patent application of Novartis AG for its cancer drug Gleevec.Assistant Controller of Patents & Designs V Rengasamy rejected the application......

Weak oil prices drag markets; Nifty ends below 7,400

Financials were the top losers while oil shares also declined amid weak crude oil prices. Benchmark share indices extended losses for the third straight session dragged by financials while oil......

How some SC judgements changed the game for corporate India

The 1995 judgment in the Union of India vs Cricket Association of Bengal case emphasised that free speech is essential for a successful democracy and citizens must have a plurality of views and a......
  Web results for Gleevec
Sun Pharma Q4 profit seen up 113%, Gleevec may drive US sales

Sun Pharma launched Gleevec generic on February 1, 2016 with 180-day exclusivity and it has already captured around 40-50 percent market share. ...

http://www.moneycontrol.com/news/result-poll/sun-pharma-q4-profit-seen113-gleevec-may-drive-us-sales_6759761.html
Sun Pharma stock up 5.8% over subsidiary Taro's strong quarterly result

Email this Print Sun Pharma stock surged 5.8 per cent today after its US subsidiary Taro Pharmaceutical Industries reported strong sales growth... ...

http://smartinvestor.business-standard.com/market/Marketnews-386516-Marketnewsdet-Sun_Pharma_stock_up_58_over_subsidiary_Taros_strong_quarterly_result.htm
Blood Cancer Treatment Market Growth, Trends and Value Chain 2016-2026

Future Market Insights has announced the addition of the Blood Cancer Treatment Market Treatment Market: Global Industry Analysis and Opportunity... ...

http://pressreleaseping.com/blood-cancer-treatment-market-growth-trends-and-value-chain-2016-2026
Colombia Threatens to Override Novartis's Patent on Gleevec

Novartis (NYSE:NVS) Intraday Stock Chart Today : Saturday 21 May 2016 By Kejal Vyas BOGOTÁ -- Colombia's government will override... ...

http://in.advfn.com/p.php?pid=nmona&article=71541552
Novartis to present pivotal data in hematologic and solid tumor cancers at 2016 ASCO Annual Meeting

From the Wires - First data from two treatment-free remission (TFR) studies of Ph+ CML patients treated with Tasigna® both in front-line and... ...

http://in.sys-con.com/node/3820419

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


gleevec
Buy Generic Gleevec Online

For Buying Imatinib & Gleevec Online...
1 Followers

gleevec
Buy Generic Gleevec 400mg Tablets Online

Imatinib mesylate 400mg tablets is a...
1 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z